UBS Group’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
Other funds holding DXCM
VCM
VPM
UBS Group's DXCM Position: Q1 2026 in Review
UBS Group increased its DexCom (DXCM) stake by 126% in Q1 2026, buying an estimated $169M and bringing the position to 4,349,959 shares worth $273M. The position accounts for 0.04% of the portfolio, ranked #471.
UBS Group first reported a position in DXCM in Q4 2014 and has held it in 46 quarters since. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.
- UBS Group held 4,349,959 shares of DexCom worth $273M as of Q1 2026.
- UBS Group bought 2,426,179 DexCom shares in Q1 2026, an estimated $169M.
- DexCom made up 0.04% of UBS Group's portfolio in Q1 2026, its #471 holding.
- UBS Group first reported a position in DexCom in Q4 2014 and has held it in 46 quarters since.
- 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.